Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jul;1(2):64-72.
doi: 10.5415/apallergy.2011.1.2.64. Epub 2011 Jul 28.

Current status of atopic dermatitis in Japan

Affiliations

Current status of atopic dermatitis in Japan

Masutaka Furue et al. Asia Pac Allergy. 2011 Jul.

Abstract

Atopic dermatitis (AD) is a common, chronic or chronically relapsing, severely pruritic, eczematous skin disease. AD is the second most frequently observed skin disease in dermatology clinics in Japan. Prevalence of childhood AD is 12-13% in mainland Japan; however, it is only half that (about 6%) in children from Ishigaki Island, Okinawa. Topical steroids and tacrolimus are the mainstay of treatment. However, the adverse effects and emotional fear of long-term use of topical steroids have induced a "topical steroid phobia" in patients throughout the world. Undertreatment can exacerbate facial/periocular lesions and lead to the development of atopic cataract and retinal detachment due to repeated scratching/rubbing/patting. Overcoming topical steroid phobia is a key issue for the successful treatment of AD through education, understanding and cooperation of patients and their guardians.

Keywords: Atopic dermatitis; Dose; History; Prevalence; Topical steroids.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Age distribution of outpatients with atopic dermatitis at the Branch Hospital, University of Tokyo.
Fig. 2
Fig. 2
Age distribution of atopic dermatitis in dermatology clinics. Report from the Japanese Dermatological Association (n = 6,733).
Fig. 3
Fig. 3
In Japan, 5-g tubes are typically used in daily clinics. Larger tubes (100 g or 50 g) are more commonly used in Europe and the USA.

References

    1. Williams HC. Is the prevalence of atopic dermatitis increasing? Clin Exp Dermatol. 1992;17:385–391. - PubMed
    1. Williams HC, Robertson C, Stewart A. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol. 1999;103:125–138. - PubMed
    1. Takeuchi M, Ueda H. Increase of adult atopic dermatitis (AD) in recent Japan. Environ Dermatol. 2000;7:133–136.
    1. Sugiura H, Umemoto N, Deguchi H, Murata Y, Tanaka K, Sawai T, Omoto M, Uchiyama M, Kiriyama T, Uehara M. Prevalence of childhood and adolescent atopic dermatitis in a Japanese population: comparison with the disease frequency examined 20 years ago. Acta Derm Venereol. 1998;78:293–294. - PubMed
    1. Sulzberger MB. Historical notes on atopic dermatitis: Its names and nature. Semin Dermatol. 1983;2:1–4.